Nano-amorphous Oral Sirolimus Formulation with Improved Exposure and Low Inter-individual Variability / Orsolya Basa-Dénes [et al.]
Bibliogr.: p. 183. - DOI: https://doi.org/10.33892/aph.2021.91.181-183
In: Acta Pharmaceutica Hungarica. - ISSN 0001-6659. - 2021. 91. évf. 3-4. sz., p. 181-183.
Kulcsszavak: Sirolimus, nano-amorphous formulation, clinical pharmacokinetics, dose escalation
